For those who see The Prince written between every line and woven into the entire tapestry of life. Innovation Pharmaceuticals posted to clinicaltrials.gov 11 days after trial, actual, start. Posted as a matter of course in the normal conduct of business. There was no waiting until the final moment allowed by regulation. There was no attempt to exploit each and every loophole to deny visibility. There was no intrigue.

There are most certainly forces working against Innovation Pharmaceuticals. Leo is undoubtedly holding his cards close to his chest. This is after all a negotiation, with potential partners and with circumstance.

But maybe, just maybe, we should consider that Innovation Pharmaceuticals' communications should be taken at face value. That, to the extent, a publicly traded company can communicate progress and goals Innovation Pharmaceuticals is forthcoming.

When Innovation Pharmaceuticals Press Releases and filings are taken a face value the story they tell is terrific. The potential for Brilacidin and Innovation Pharmaceutical in general is great.

GLTA(Longs)